Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-071615
Filing Date
2022-11-14
Accepted
2022-11-14 08:02:09
Documents
2
Period of Report
2022-11-14

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea168497-6k_universe.htm 6-K 10510
2 PRESS RELEASE - UNIVERSE PHARMACEUTICALS INC REGAINS COMPLIANCE WITH NASDAQ MINI ea168497ex99-1_universe.htm EX-99.1 7065
  Complete submission text file 0001213900-22-071615.txt   18670
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

EIN.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40231 | Film No.: 221380445
SIC: 2834 Pharmaceutical Preparations